Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bassam Damaj currently holds 6,852,322 shares of INNOVUS PHARMACEUTICALS, INC. (INNV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bassam Damaj has been a net buyer of INNV stock. They have purchased $379.9K and sold $0 worth of shares.
Bassam Damaj's most recent insider trade was on Jun 26, 2015, when they sold 50 shares at $0.12 per share.
Bassam Damaj serves as Executive at INNOVUS PHARMACEUTICALS, INC. (INNV). They have executed 21 insider transactions totaling $379.9K over their tenure at the company.
Bassam Damaj holds the position of Executive at INNOVUS PHARMACEUTICALS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 17 years and currently hold a stake valued at $0.
Bassam Damaj has shown a buying trading pattern, with $379.9K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Bassam Damaj was on Jun 21, 2010, when they purchased $1.2M worth of NEXM shares. This transaction involved 483,372 shares at $2.52 per share.
Bassam Damaj currently owns 6,852,322 shares of INNOVUS PHARMACEUTICALS, INC. (INNV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bassam Damaj's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bassam Damaj has 21 Form 4 filings on record as an insider at INNOVUS PHARMACEUTICALS, INC..
Set alerts for Bassam Damaj and 40,000+ other insiders.